Trials

  • July 27, 2026

    Albertsons Opioid Trial Told Of Needles, ODs In Library

    A witness in Washington's case accusing Albertsons Cos. Inc. of fueling the state's opioid crisis testified at a bench trial Monday that problem drug use was evident in a city library system she's led for nearly a decade, pointing to syringes scattered across the facility and multiple instances of overdoses.

  • July 27, 2026

    J&J, Ovarian Cancer Talc Claimants Unveil $5.5B Global Deal

    Johnson & Johnson announced Monday that it has agreed to pay some $5.5 billion to put to rest tens of thousands of lawsuits alleging its talcum powder products caused ovarian cancer, with plaintiffs' counsel calling the deal "long-delayed justice" for their clients.

  • July 27, 2026

    Meta Left Users In Dark About Danger, Tenn. AG Tells Jury

    Tennessee's attorney general went to trial Monday against Meta over claims the social media giant concealed teen mental health harms, telling a jury that despite the revelations employees saw from its systematic research program, the public "warning never came."

  • July 27, 2026

    Fed. Circ. Clears Boston Scientific In $49M Stent Patent Case

    The Federal Circuit on Monday overturned a $49.4 million patent judgment against Boston Scientific, ruling that the company's drug-eluting coronary stents did not infringe a patent owned by the University of Texas System and that the patent is invalid.

  • July 27, 2026

    7th Circ. Asked To Clarify Copyright Prevailing Party Status

    A man who successfully defended himself from being held liable for damages when he was sued by a food photography company that claimed his photo of raw meat on Facebook counted as copyright infringement has asked the Seventh Circuit to find that he's the "prevailing party" for purposes of seeking attorney fees.

  • July 27, 2026

    Epic Says Google Wants To Hide Rival App Stores In Search

    Epic Games and Google asked the California federal judge overseeing the gaming giant's antitrust battle against the tech giant to resolve a dispute over whether the court's injunction requires rival app stores to be shown in Play Store search results or whether Google can "relegate" rivals to a separate page.

  • July 27, 2026

    Calif. Judge Doubts AI Citation Case Fits Diversion Program

    A State Bar of California judge on Monday explained her decision to decline to refer an attorney to the bar's alternative discipline program for allegedly using nonexistent citations drafted with artificial intelligence, saying the attorney did not provide any grounds for such a referral and she is unsure there could be any such grounds.

  • July 27, 2026

    Cooley Owes $25.4M Judgment To NJ Biotech Co. Founder

    A New Jersey state court on Monday entered a $25.4 million judgment against Cooley LLP after a jury found the multinational firm had committed malpractice in its representation of a biotech founder who said his own lawyers assisted in shoving him out of his company.

  • July 27, 2026

    FTC Reaches Deal With Corteva In Pesticides Rebate Case

    Corteva told a North Carolina federal court Monday that it reached a settlement with the Federal Trade Commission in a case accusing the pesticide maker of blocking competition from generic rivals through the use of loyalty rebates.

  • July 27, 2026

    4th Circ. Says Inmate Can Represent Himself At Sentencing

    The Fourth Circuit held Monday that the Sixth Amendment rights of a South Carolina man were violated when a judge denied him the ability to represent himself during sentencing because he did not make the request prior to the start of his drug-trafficking trial.

  • July 27, 2026

    Google Can't Get 2nd Try At Eliminating Network-1 Patent

    A New York federal judge has denied Google's request for a second attempt at invalidating a patent asserted by a patent licensing company, rejecting its arguments that a Federal Circuit decision from last month made another try necessary.

  • July 27, 2026

    Yale, Biohaven Win $4M In Biotech Trade Secret Trial

    A Delaware federal jury has awarded Yale University and Biohaven Therapeutics $4 million after finding that venture capital firm RA Capital Management GP breached a confidentiality agreement and, along with co-defendant Avilar Therapeutics, misappropriated a Yale-developed trade secret for designing protein-degrading drug molecules.

  • July 27, 2026

    Samsung Owes $92.3M After Judge Boosts Media IP Award

    A Texas federal judge has heaped $13.8 million in prejudgment interest on top of a $78.5 million jury award owed by Samsung after it was found to infringe a pair of patents covering automatic content recognition technology for commercial advertising.

  • July 27, 2026

    Wells Fargo Finance Manager Drops Bias Suit Ahead Of Trial

    A finance manager for Wells Fargo has ended her disability bias suit accusing the bank of discriminating against her after she sought to continue working from home to deal with health issues, cutting short the case ahead of a tentative September trial date.

  • July 27, 2026

    Simpson Thacher Atty Says Patriot Nat'l Founder Sank Co.

    A Simpson Thacher & Bartlett LLP partner wrapped up her testimony Monday in a Florida state malpractice trial brought by the founder of Patriot National Inc., telling the jury that the founder was willing to forgo establishing a floor on the value of so-called Series B warrants, which he says contributed to the company's demise.

  • July 27, 2026

    Pa. Landfill Owner Hit With $9.2M Water Pollution Judgment

    Republic Services' six-year-long delay in expanding water treatment facilities at a Pennsylvania landfill led a federal judge to impose a $9.2 million civil penalty for violations of the Clean Water Act.

  • July 27, 2026

    Regeneron Says Drug Approval Irrelevant In Antitrust Case

    Regeneron told a Delaware federal court the recent regulatory approval of a new cholesterol drug is irrelevant to its case accusing Amgen of bundling Repatha with other medications, as the court mulls an injunction bid following Regeneron's $407 million jury win.

  • July 27, 2026

    Live Nation, DOJ Say States Have Enough Discovery Into Deal

    The U.S. Department of Justice has joined with Live Nation to resist a discovery request by a bipartisan group of state attorneys general seeking more information about a settlement the federal government reached with the company in the middle of an antitrust trial.

  • July 27, 2026

    300+ Public Defenders Strike In The Bronx

    More than 300 attorneys and staff with the Bronx Defenders Union went on strike Monday, one year after the last time the union walked off the job.

  • July 27, 2026

    Mexico Billionaire Not Financier's Only Victim, Judge Told

    A Greek financier who allegedly swiped $450 million from Mexican billionaire Ricardo Salinas Pliego in a fraudulent stock-for-cash loan deal has "numerous other victims," a prosecutor told a Manhattan federal judge Monday.

  • July 24, 2026

    Phillips 66 Inks Deal To End Patent Case Revived By Fed. Circ.

    Phillips 66 has settled allegations it infringed Magema Technology's oil refinery patents, reaching a deal nearly a year after the Federal Circuit held that ordered a new trial in the yearslong battle.

  • July 24, 2026

    Panel Asks Fla. Justices To Clarify Right-To-Counsel Rule

    A Florida appeals court has concluded that while a man's sexual battery conviction should remain in place, the state's highest court should determine whether the Florida Constitution allows attorney-client conversations during a recess when barred by a trial judge.

  • July 24, 2026

    Fla. Panel To Prosecutors: 'Double-Check' Charging Docs

    Florida appellate judges reversed a man's fentanyl trafficking conviction Friday after finding the substance found on him during a traffic stop was not fentanyl, but a fentanyl derivative, remarking, "'issues like this should be avoided by the state taking a moment to double-check its charging documents.'"

  • July 24, 2026

    Balancing The Scales: Geofence Clarity, Post-Hunter Scrutiny

    The U.S. Supreme Court deemed geofence warrants as searches under the Fourth Amendment, and the justices’ ruling in Hunter spurs a conversation of what the bar should be for criminal appeal waivers. Here, Law360 highlights access to justice stories arising from litigation, verdicts and judgments you may have missed.

  • July 24, 2026

    Fannie, Freddie Investors' $612M Trial Win Affirmed

    The D.C. Circuit on Friday affirmed a $612 million jury verdict against the Federal Housing Finance Agency, Fannie Mae and Freddie Mac, agreeing with a lower court's finding that the jury was provided with "ample evidence" reasonably leading to its conclusion that FHFA improperly amended stock purchase agreements related to the companies.

Expert Analysis

  • Considerations When Invoking The Common-Interest Privilege

    Author Photo

    To successfully leverage the common-interest doctrine in a multiparty transaction or complex litigation, practitioners should be able to demonstrate that the parties intended for it to apply, that an underlying privilege like attorney-client has attached, and guard against disclosures that could waive privilege and defeat its purpose, say attorneys at DLA Piper.

  • How In-House Counsel Can Prep Corp. Reps For Depositions

    Author Photo

    With anticorporate sentiment on the rise and jury verdicts against businesses growing larger, it is crucial that witnesses designated to be deposed on behalf of a company be well-prepared — and there are several key points in-house counsel should keep in mind to facilitate this process, says Joseph Altieri at Hollingsworth.

  • How Marsy's Law Has Been Applied In Unexpected Ways

    Author Photo

    Since Marsy’s Law was first passed in California 17 years ago, 12 states have passed similar laws to protect crime victims’ rights, but recent developments show that it’s being applied in ways that its original proponents may never have anticipated — with implications for all legal practitioners, says Tom Jones at Berk Brettler.

  • Series

    The Law Firm Merger Diaries: Making The Case To Combine

    Author Photo

    When making the decision to merge, law firm leaders must factor in strategic alignment, cultural compatibility and leadership commitment in order to build a compelling case for combining firms to achieve shared goals and long-term success, says Kevin McLaughlin at UB Greensfelder.

  • 1st Trial After FCPA Pause Offers Clues On DOJ Priorities

    Author Photo

    After surviving a government review of Foreign Corrupt Practices Act enforcement, the U.S. v. Zaglin case reveals the U.S. Department of Justice still appears willing to prosecute individuals for conduct broadly consistent with classic priorities, despite the agency's new emphasis on foreign policy priorities, say attorneys at Debevoise.

  • Opinion

    Despite Deputy AG Remarks, DOJ Can't Sideline DC Bar

    Author Photo

    Deputy Attorney General Todd Blanche’s recent suggestion that the D.C. Bar would be prevented from reviewing misconduct complaints about U.S. Department of Justice attorneys runs contrary to federal statutes, local rules and decades of case law, and sends the troubling message that federal prosecutors are subject to different rules, say attorneys at HWG.

  • How Trial Attys Can Sidestep Opponents' Negative Frames

    Author Photo

    In litigation, attorneys often must deny whatever language or association the other side levies against them, but doing so can make the associations more salient in the minds of fact-finders, so it’s essential to reframe messages in a few practical ways at trial, says Ken Broda-Bahm at Persuasion Strategies.

  • 10th Circ. Debtor Ruling May Expand Wire Fraud Law Scope

    Author Photo

    The Tenth Circuit’s recent U.S. v. Baker decision, holding that federal fraud law can reach deceptive schemes designed to prevent a creditor from collecting on a debt, may represent an expansive new theory of wire fraud — even as the ruling reaffirmed the requirements of the interstate commerce element, say attorneys at ArentFox Schiff.

  • Rule Amendments Pave Path For A Privilege Claim 'Offensive'

    Author Photo

    Litigators should consider leveraging forthcoming amendments to the Federal Rules of Civil Procedure, which will require early negotiations of privilege-related discovery claims, by taking an offensive posture toward privilege logs at the outset of discovery, says David Ben-Meir at Ben-Meir Law.

  • Series

    My Miniature Livestock Farm Makes Me A Better Lawyer

    Author Photo

    Raising miniature livestock on my farm, where I am fully present with the animals, is an almost meditative time that allows me to return to work invigorated, ready to juggle numerous responsibilities and motivated to tackle hard issues in new ways, says Ted Kobus at BakerHostetler.

  • Litigation Funding Could Create Ethics Issues For Attorneys

    Author Photo

    A litigation investor’s recent complaint claiming a New York mass torts lawyer effectively ran a Ponzi scheme illustrates how litigation funding arrangements can subject attorneys to legal ethics dilemmas and potential liability, so engagement letters must have very clear terms, says Matthew Feinberg at Goldberg Segalla.

  • E-Discovery Quarterly: Recent Rulings On Dynamic Databases

    Author Photo

    Several recent federal court decisions illustrate how parties continue to grapple with the discovery of data in dynamic databases, so counsel involved in these disputes must consider how structured data should be produced consistent with the requirements of the Federal Rules of Civil Procedure, say attorneys at Sidley.

  • Comey Case Highlights Complex Speedy Trial Rights Calculus

    Author Photo

    Former FBI Director James Comey’s decision to waive his Speedy Trial Act rights in the false statement prosecution against him serves as a reminder that the benefits of invoking these rights are usually outweighed by the risks of inadequate preparation, but it can be an effective strategy in the right case, says Sara Kropf at Kropf Moseley.

  • Reel Justice: 'Roofman,' Modus Operandi Evidence And AI

    Author Photo

    The recent film “Roofman,” which dramatizes the real-life string of burglaries committed by Jeffrey Manchester, illuminates the legal standards required to support modus operandi evidence — which may soon become complicated by the use of artificial intelligence in crime series detection, says Veronica Finkelstein at Wilmington University School of Law.

  • Series

    Building With Lego Makes Me A Better Lawyer

    Author Photo

    Building with Lego has taught me to follow directions and adapt to unexpected challenges, and in pairing discipline with imagination, allows me to stay grounded while finding new ways to make complex deals come together, says Paul Levin at Venable.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Trials archive.